Industry News

Surgery Partners, Inc., a leading healthcare services company, today announced that CEO Mike Doyle and CFO Teresa Sparks will present at the 2016 Morgan Stanley Global Healthcare Conference, on Sept. 13th, 2016, in New York, NY. The presentation will begin at 1:30 PM ET. Interested investors and other parties may listen to a simultaneous webcast of the presentation by logging on to the Investor Relations section of the company's website at..."/>
Surgery Partners, Inc. to Present at the 2016 Morgan Stanley Global Healthcare Conference
LHC Group, Inc. announced today that Keith G. Myers, chief executive officer of LHC Group, will present at the 2016 Wells Fargo Healthcare Conference in Boston, Massachusetts, on Thursday, September 8, 2016.. The presentation will begin at 3:30 p.m. Eastern time. To access a live webcast of LHC Group’ s presentation, listeners should go to the Investor Relations section of the Company’ s website, www.LHCgroup.com, approximately 15 minutes prior to the event..."/>
LHC Group to Present at 2016 Wells Fargo Healthcare Conference
K2M Group Holdings, Inc., a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced management will present at the following investor conferences in September:. The 2016 Wells Fargo Healthcare Conference at the Westin Boston Waterfront in Boston, Massachusetts. Management will present on Thursday,..."/>
K2M Group Holdings, Inc. to Present at Two Investor Conferences in September
Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with Ian Read, Chairman and Chief Executive Officer, at the 2016 Wells Fargo Healthcare Conference on Thursday, September 8, 2016 at 12:15 p.m. Eastern Daylight Time. To listen to the webcast, visit our web site at www.pfizer.com and click on the“ 2016 Wells Fargo Healthcare Conference” link in the For Investors section located on the lower right-hand corner of that page."/>
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Biocon Ltd, on Thursday said its chairperson and managing director Kiran Mazumdar-Shaw has been appointed' Chevalier de l'Ordre National de la Légion d'Honneur' or Knight of the National Order of the French Legion of Honour for her outstanding contribution and dedication to the biosciences and research field globally. "The award will be conferred on behalf of the President of the French Republic at a special ceremony later this..."/>
BRIEF: Kiran Mazumdar-Shaw conferred knighthood by French government [Mint, New Delhi]
IIROC Trade Resumption - CTX
Pfizer Inc., the Eastern Connecticut Symphony Orchestra, Eugene O'Neill Theatre Center and the town and cities of Groton and New London. Those were just some of the 40 or so supporters who showed up Wednesday for the first public airing of an initiative intended to attract high-growth companies to the region. Meeting at the Harris Building Conference Center on State Street as a part of..."/>
Innovation Place initiative garners suppport [The Day, New London, Conn.]
PAREXEL International Corporation announced today it will be presenting at the Wells Fargo Healthcare Conference on Wednesday September 7, 2016 in Boston. Josef von Rickenbach, Chairman and Chief Executive Officer, will be making a presentation on PAREXEL and discussing business developments at 9:20a.m. ET. A live webcast of the presentation will be available through the“ Investors” section of PAREXEL’ s website at www.PAREXEL.com in the Upcoming Events portion of..."/>
PAREXEL International to Present at Wells Fargo Healthcare Conference
Regeneron Pharmaceuticals, Inc. will webcast a management presentation at the following investor conferences:. 2016 Credit Suisse Antibody Day at 10:00 a.m. Eastern Time on Wednesday, September 7, 2016 Morgan Stanley Global Healthcare Conference at 11:40 a.m. Eastern Time on Monday, September 12, 2016 Bank of America Merrill Lynch Global Healthcare Conference at 6:25 a.m. Eastern Time on Wednesday, September 14, 2016."/>
Regeneron Announces Upcoming 2016 Investor Conference Presentations
Knight Therapeutics Inc., a leading Canadian specialty pharmaceutical company, announced today that its strategic partner INTEGA Skin Sciences Inc., a Montreal-based dermatology company, has been acquired by Crescita Therapeutics Inc. for base consideration of $8.0 million payable in Crescita common shares valued at $2.44 a share. In January 2016, Knight entered into a secured loan agreement with INTEGA pursuant to which Knight loaned over..."/>
Knight Therapeutics Inc.: INTEGA Skin Primed for Crescita (Italian for Growth)
IIROC Trading Halt - CTX
PharmaCyte Biotech, Inc., a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box ®, today provided an update on its program for developing treatments for serious brain cancers that involve constituents of the Cannabis plant. These Cannabis- based cancer therapies, like PharmaCyte’ s pancreatic cancer therapy, will..."/>
PharmaCyte Biotech Reports on Progress in Its Medical Cannabis Program
AMAG Pharmaceuticals, Inc. today announced that company management will participate in an analyst-led fireside chat at the Morgan Stanley Global Healthcare Conference on Monday, September 12, 2016 at 10:30 a.m. EDT.. A live audio webcast of the discussion will be accessible through the Investors section of the company’ s website at www.amagpharma.com and will be archived for 30 days. About AMAG AMAG is a biopharmaceutical company focused on..."/>
AMAG Pharmaceuticals to Present at Upcoming Investor Conference
Crescita Therapeutics Inc., a drug development company that owns topical products for use in the treatment of medical conditions related to dermatology and pain, today announced that it has acquired INTEGA Skin Sciences Inc., a Montreal-based dermatology company which develops, manufactures, sells and markets science-based quality skin care products."/>
Crescita Therapeutics™ Inc. Announces Acquisition of INTEGA Skin Sciences
Crescita Therapeutics Inc., a drug development company that owns topical products for use in the treatment of medical conditions related to dermatology and pain, today announced that it has acquired INTEGA Skin Sciences Inc., a Montreal-based dermatology company which develops, manufactures, sells and markets science-based quality skin care products."/>
Crescita Therapeutics™ Inc. Announces Acquisition of INTEGA Skin Sciences
Cerecor Inc., a clinical-stage biopharmaceutical company developing treatments to make a difference in the lives of patients with neurological and psychiatric disorders, today announced it will be featured as a presenting company at the 23 rd Annual NewsMakers in the Biotech Industry Conference. The conference is being held on September 9, 2016, at the Millennium Broadway Hotel in New York City. Uli Hacksell, President and Chief Executive Officer of Cerecor, will..."/>
Cerecor to Present at 23rd Annual NewsMakers in the Biotech Industry Conference in New York City, September 9, 2016
Inovio Pharmaceuticals, Inc. today announced that the Company will present a corporate overview at the following upcoming conferences:. Citi 11th Annual Biotech Conference Mandarin Oriental, Boston, Thursday, September 8 th, 1 x1 meetings. 23 rd Annual Newsmakers in the Biotech Industry Millennium Broadway Hotel, New York, Friday, September 9 th, 11:00 am ET."/>
Inovio Pharmaceuticals to Present at Upcoming Investment Conferences
Apple has provoked a multitude of different reactions across the Atlantic. In Congress and on the presidential election trail there has been mild approval. No-one likes tax cheats and there is strong US political momentum aimed at repatriating the trillions of dollars of reserves that US companies have been accumulating in Bermuda and elsewhere to reinvest in the domestic economy."/>
Daily Mail, London, Alex Brummer column [Daily Mail, London]
Perrigo Company plc today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of Epiduo ® Gel. Epiduo ® Gel is indicated for the treatment of acne vulgaris in patients 12 years of age and older."/>
Perrigo Announces Tentative FDA Approval For Generic Version Of Epiduo® Gel
RedHill Biopharma Ltd., a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that Mr. Adi Frish, RedHill’ s Senior VP Business Development& Licensing, will be presenting at the 9 th Annual BioPharm America International Partnering Conference, on Wednesday,..."/>
RedHill Biopharma to Present at the 9th Annual BioPharm America International Partnering Conference
St. Jude Medical AMPLATZER™ Amulet™ IDE trial, which will evaluate the safety and effectiveness of the company’ s AMPLATZER™ Amulet™ Left Atrial Appendage Occluder used to close the left atrial appendage..."/>
St. Jude Medical Launches Global Clinical Trial to Evaluate a New Therapy Option for Patients at an Increased Risk of Stroke Due to Atrial Fibrillation
Cerner client Sharp HealthCare, a leading health care provider in San Diego, has selected Cerner, a global leader in health care technology, to extend its electronic health record to Sharp Community Medical Group, one of two affiliated medical groups.. The PowerChart Ambulatory™ EHR will support more than 200 primary care and specialty physicians across Sharp’ s outpatient facilities and independent physician practices. Integration with the..."/>
Sharp HealthCare to Expand Cerner Digital Record
Evogene Ltd., a leading biotechnology company for the improvement of crop productivity for the food, feed and fuel industries, today announced it will be featured as a presenting company at the 18 th Annual Rodman& Renshaw Global Investment Conference. The conference is being held on September 11-13, 2016, at Lotte New York Palace Hotel in New York City.. Ofer Haviv, Evogene President and Chief Executive Officer, will provide an overview of the..."/>
Evogene Announces Participation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 11-13th, 2016
Aviragen Therapeutics, Inc., a pharmaceutical company that is developing the next generation of antivirals, today announced that management will host a conference call on Thursday, September 8, 2016 at 4:30 p.m. ET to review the Company’ s financial results for the three month period and 2016 fiscal year ended June 30, 2016 and will provide an update on recent corporate developments. The Company will issue a press release summarizing its financial..."/>
Aviragen Therapeutics to Host Conference Call to Report Fourth Quarter and Fiscal Year 2016 Financial Results on September 8, 2016

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Consumer Discretionary492 Articles
Information Technology489 Articles
Financials316 Articles
Industrials291 Articles
Health Care269 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.